Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2010

Feb 23, 2010

29777_dirs_2010-02-22_b5744ebe-7dd1-40d3-b39c-567db043a8f3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2010-02-19

Reporting Person: OWEN DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-19 Common shares without par value M 5010 $35.9192 Acquired 17098 Direct
2010-02-19 Common shares without par value S 2800 $54.282 Disposed 14298 Direct
2010-02-19 Common shares without par value S 1800 $54.281 Disposed 12498 Direct
2010-02-19 Common shares without par value S 110 $54.2812 Disposed 12388 Direct
2010-02-19 Common shares without par value S 100 $54.2815 Disposed 12288 Direct
2010-02-19 Common shares without par value S 200 $54.2816 Disposed 12088 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-02-19 Option (right to buy) $35.9192 M 5010 Disposed 2010-04-27 Common shares (5010) Direct

Footnotes

F1: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.